Горбань Н. А.¹, Колдаева М. С.^{2, 3}, Меньшикова Е. Е.⁴

¹ФГБУ «Центральная клиническая больница с поликлиникой» Управления делами Президента РФ; Россия, 121359 Москва, ул. Маршала Тимошенко, 15;

²ГБУЗ «Московский клинический научный центр им. А. С. Логинова Департамента здравоохранения г. Москвы»; Россия, 111123 Москва, ш. Энтузиастов, 86, стр. 6;

³Научно-клинический центр № 2 ФГБНУ «Российский научный центр хирургии им. акад. Б. В. Петровского»; Россия, 117593 Москва, Литовский бульвар, 1А;

⁴Emory University School of Medicine; 1364 Clifton Rd NE, Atlanta, GA, USA 30322

1. WHO Classification of Tumours Editorial Board. Tumours of the urinary tract. In: WHO Classification of Tumours. Urinary and male genital tumours. 5th ed. Geneva, Switzerland: WHO Press, 2022.

2. Sylvester R.J., Rodríguez O., Hernández V. et al. European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel. Eur Urol 2021;79(4):480–8. DOI: 10.1016/j.eururo.2020.12.033. Erratum in: Eur Urol 2023;83(5):e140–e141. DOI: 10.1016/j.eururo.2023.02.007

3. Mostofi F.K., Sobin L.H., Torloni H. Histological Typing of Urinary Bladder Tumors: International Classification of Tumors. Geneva: World Health Organization, 1973: no. 10: 17.

4. Eble J., Sauter G., Epstein J., Sesterhenn I. (2004) Pathology and genetics of tumours of the urinary system and male genital organs: World Health Organization. IARC Press, Lyon.

5. Montironi R., Lopez-Beltran A., Mazzucchelli R., Bostwick D.G. Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies. J Clin Pathol 2003;56(2):91–5. DOI: 10.1136/jcp.56.2.91

6. Bostwick D.G., Mikuz G. Urothelial papillary (exophytic) neoplasms. Virchows Arch 2002;441(2):109–16. DOI: 10.1007/s00428-002-0624-y

7. Busch C., Algaba F. The WHO/ISUP 1998 and WHO 1999 systems for malignancy grading of bladder cancer. Scientific foundation and translation to one another and previous systems. Virchows Arch 2002;441(2):105–8. DOI: 10.1007/s00428-002-0633-x

8. Chen Z., Ding W., Xu K. et al. The 1973 WHO Classification is more suitable than the 2004 WHO Classification for predicting prognosis in non-muscle-invasive bladder cancer. PLoS One 2012;7(10):e47199. DOI: 10.1371/journal.pone.0047199

9. Otto W., Denzinger S., Fritsche H.M. et al. The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer. BJU Int 2011;107(3):404–8. DOI: 10.1111/j.1464-410X.2010.09515.x

10. Guan B., Tang S., Zhan Y. et al. Prognostic performance of the 1973 and 2004 WHO grading classification in upper tract urothelial carcinoma. Urol Oncol 2019;37(8):529.e19–529.e25. DOI: 10.1016/j.urolonc.2019.01.013

11. van de Putte E.E.F., Bosschieter J., van der Kwast T.H. et al. The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non-muscle-invasive bladder cancer. BJU Int 2018;122(6):978–85. DOI: 10.1111/bju.14238

12. Cao D., Vollmer R.T., Luly J. et al. Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma. Urology 2010;76(3):593–9. DOI: 10.1016/j.urology.2010.01.032

13. Burger M., van der Aa M.N., van Oers J.M. et al. Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study. Eur Urol 2008;54(4):835–43. DOI: 10.1016/j.eururo.2007.12.026

14. Collà Ruvolo C., Würnschimmel C., Wenzel M. et al. Comparison between 1973 and 2004/2016 World Health Organization grading in upper tract urothelial carcinoma treated with radical nephroureterectomy. Int J Clin Oncol 2021;26(9):1707–13. DOI: 10.1007/s10147-021-01941-9

15. Pellucchi F., Freschi M., Ibrahim B. et al. Clinical reliability of the 2004 WHO histological classification system compared with the 1973 WHO system for Ta primary bladder tumors. J Urol 2011;186(6):2194–9. DOI: 10.1016/j.juro.2011.07.070

16. Downes M.R., Lajkosz K., Kuk C. et al. The impact of grading scheme on non-muscle invasive bladder cancer progression: potential utility of hybrid grading schemes. Pathology 2022;54(4):425–33. DOI: 10.1016/j.pathol.2021.10.005

17. Collà Ruvolo C., Würnschimmel C., Wenzel M. et al. Comparison between 1973 and 2004/2016 WHO grading systems in patients with Ta urothelial carcinoma of urinary bladder. J Clin Pathol 2022;75(5):333–7. DOI: 10.1136/jclinpath-2021-207400

18. van Rhijn B.W.G., Hentschel A.E., Bründl J. et al. Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscleinvasive Bladder Cancer Guidelines Panel Study. Eur Urol Oncol 2021;4(2):182–91. DOI: 10.1016/j.euo.2020.12.002

19. Liedberg F., Lauss M., Patschan O. et al. The importance of being grade 3: WHO 1999 versus WHO 2004 pathologic grading. Eur Urol 2012;62(4):620–3. DOI: 10.1016/j.eururo.2012.05.063

20. Reis L.O., Dal Col L.S.B. et al. Presence and predominance of histological grade 3 define cT1HG bladder cancer prognostic groups. Investig Clin Urol 2022;63(1):21–6. DOI: 10.4111/icu.20210386

21. Jahnson S., Jancke G., Olsson H., Aljabery F. Bladder cancer grading using the four-tier combination of the World Health Organization (WHO) 1973 and WHO 2004 classifications. BJU Int 2023;132(6):656–63. DOI: 10.1111/bju.16100